Cytotoxic T-lymphocytes (CTL)
Recognition of clonogenic leukemic cells, remission bone marrow and HLA identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen specific cytotoxic T lymphocytes
8
Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes.
6
Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
8
Cytotoxic T lymphocytes form an antigen independent ring junction
10
CD40 Ligand-Mediated Interactions Are Involved in the Generation of Memory CD8+ Cytotoxic T Lymphocytes (CTL) but Are Not Required for the Maintenance of CTL Memory following Virus Infection
10
Kinetics of Antiviral Activity by Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes (CTL) and Rapid Selection of CTL Escape Virus In Vitro
7
The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors
12
Effects of Cytotoxic T Lymphocytes (CTL) Directed against a Single Simian Immunodeficiency Virus (SIV) Gag CTL Epitope on the Course of SIVmac239 Infection
5
Normal self proteins as targets for tumour specific cytotoxic T lymphocytes (CTL)
318
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
11
Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes
9
Enhanced presentation of MHC class Ia, Ib and class II restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy
10
Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans.
7
Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
9
Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection.
7
Virotheranostics, a double-barreled viral gun pointed toward cancer; ready to shoot?
17
<p>T cells targeting multiple tumor-associated antigens as a postremission treatment to prevent or delay relapse in acute myeloid leukemia</p>
10
HLA dependent tumour development: a role for tumour associate macrophages?
15
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP 1 and loss of expression of the immunodominant MART 1/Melan A antigen
10
Targeting the inflammation in HCV associated hepatocellular carcinoma: a role in the prevention and treatment
11